King Luther Capital Management Corp Regeneron Pharmaceuticals, Inc. Transaction History
King Luther Capital Management Corp
- $23 Billion
- Q3 2024
A detailed history of King Luther Capital Management Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 842 shares of REGN stock, worth $621,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
842
Previous 831
1.32%
Holding current value
$621,396
Previous $873,000
1.37%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,531Shares Held
84.1MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.88 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.23 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.53 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.62 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.17 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $79.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...